Kalaris Therapeutics (KLRS) Return on Assets [ROA] (2020 - 2026)
Kalaris Therapeutics (KLRS) recorded Return on Assets [ROA] of -45.63% in Q2 2026, up 24.07 percentage points from -69.70% a year earlier but down 4.49 percentage points from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Return on Assets [ROA] (2020 - 2026) Analysis & Trends
For FY2025, Kalaris Therapeutics reported Return on Assets [ROA] of -74.43%, down 14.75 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of -47.07 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -59.68% in FY2024 (+21.72 pp), -81.40% in FY2023 (-21.54 pp), -59.86% in FY2022 (-7.55 pp) and -52.31% in FY2021 (-24.96 pp).
- Quarterly Return on Assets [ROA] has ranged from -108.64% in Q1 2025 to -41.14% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Assets [ROA] has increased for five consecutive quarters, with an average year-over-year change of +16.97 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 67.50 percentage points in Q1 2026, against a drop of 54.27 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -41.14% (Q1 2026), -46.91% (Q4 2025) and -50.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | -45.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.63% |
| Mar 31, 2026 | -41.14% |
| Dec 31, 2025 | -46.91% |
| Sep 30, 2025 | -50.40% |
| Jun 30, 2025 | -69.70% |
| Mar 31, 2025 | -108.64% |
| Dec 31, 2024 | -76.07% |
| Sep 30, 2024 | -80.14% |
| Jun 30, 2024 | -79.01% |
| Mar 31, 2024 | -89.94% |
| Dec 31, 2023 | -87.06% |
| Sep 30, 2023 | -63.85% |
| Jun 30, 2023 | -63.54% |
| Mar 31, 2023 | -64.00% |
| Dec 31, 2022 | -59.12% |
| Sep 30, 2022 | -75.98% |
| Jun 30, 2022 | -88.61% |
| Mar 31, 2022 | -71.05% |
| Dec 31, 2021 | -56.50% |
| Sep 30, 2021 | -42.94% |
API Access
Kalaris Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();